Feline hypertrophic cardiomyopathy: Does the microRNA‐mRNA regulatory network contribute to heart sarcomeric protein remodelling?

Feline primary hypertrophic cardiomyopathy (HCM) is an intrinsic myocardial disease characterized by concentric hypertrophy of the left ventricle. In the present study, we investigated the microRNA‐mRNA regulatory network in feline myocardial tissue affected by primary (HCMI) and secondary HCM (HCMI...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of experimental pathology 2024-10, Vol.105 (5), p.170-183
Hauptverfasser: Guelfi, Gabriella, Venanzi, Noemi, Capaccia, Camilla, Stefanetti, Valentina, Brachelente, Chiara, Sforna, Monica, Porciello, Francesco, Lepri, Elvio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Feline primary hypertrophic cardiomyopathy (HCM) is an intrinsic myocardial disease characterized by concentric hypertrophy of the left ventricle. In the present study, we investigated the microRNA‐mRNA regulatory network in feline myocardial tissue affected by primary (HCMI) and secondary HCM (HCMII). MRNA expression levels of sarcomeric genes, including, TNNT2, TNNI3, MYH7, MYBPC3, TPM1 and ACTC1 were assessed in the FFPE myocardial tissues. FFPE tissues from healthy cats were sequenced by the NGS, to explore, in the entire non‐deposited miRNome, the expression level of microRNAs targeting the complementary sequences of selected sarcomeric mRNAs. The sarcomeric genes TNNT2, MYH7, MYBPC3 and TPM1 showed a statistically significant upregulation in HCMI compared to HCMII (p 
ISSN:0959-9673
1365-2613
1365-2613
DOI:10.1111/iep.12514